cell therapy companies

Companies whose enriched business profile is tagged “cell therapy”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.

• Gilead Sciences (GILD) Health Care — A leading biopharmaceutical innovator specializing in life-saving HIV therapies and complex CAR T-cell cancer treatments. ask →
• IMMUNITYBIO INC (IBRX) Health Care — ImmunityBio develops innovative immunotherapies and cell-based cancer vaccines that leverage its Cancer BioShield platform to treat oncology and infectious disease patients. ask →
• IOVANCE BIOTHERAPEUTICS INC (IOVA) Health Care — Iovance is a pioneer in tumor infiltrating lymphocyte (TIL) cell therapy, offering the first one-time, individualized T cell treatment for advanced solid tumor cancers. ask →
• CRISPR THERAPEUTICS AG (CRSP) Health Care — CRISPR Therapeutics is a biopharmaceutical company pioneering gene-editing therapies to treat and potentially cure severe genetic diseases using its proprietary CRISPR/Cas9 technology. ask →
• PRECIGEN INC (PGEN) Health Care — A commercial-stage precision medicine company leveraging proprietary adenoviral and CAR-T platforms to address intractable diseases, notably including the FDA-approved RRP therapy Papzimeos. ask →
• VERICEL CORP (VCEL) Health Care — Vericel is a commercial-stage biotechnology company that develops and markets autologous cell therapies for the treatment of severe burns and cartilage damage in the knee. ask →
• VOR BIOPHARMA INC (VOR) Health Care — Vor Biopharma is a clinical-stage biotech firm engineering hematopoietic stem cells to create safer and more effective treatment regimens for patients with blood cancers. ask →
• SANA BIOTECHNOLOGY INC (SANA) Health Care — Sana Biotechnology is a biotechnology company leveraging gene editing and cell engineering technologies to develop a pipeline of transformative, engineered cell-based therapies. ask →
• PROKIDNEY CORP CLASS A (PROK) Health Care — ProKidney is a biotech company developing a first-in-class, personalized autologous cell therapy to preserve kidney function in patients with advanced chronic kidney disease and diabetes. ask →
• CAPRICOR THERAPEUTICS INC (CAPR) Health Care — A clinical-stage biotechnology company developing novel cell and exosome-based therapies for Duchenne muscular dystrophy and other rare diseases. ask →
• KYVERNA THERAPEUTICS INC (KYTX) Health Care — Kyverna Therapeutics is a late-stage clinical company developing potentially curative CAR T-cell therapies for patients with severe neurologic autoimmune diseases. ask →
• ARTIVA BIOTHERAPEUTICS INC (ARTV) Health Care — Artiva Biotherapeutics is developing off-the-shelf, allogeneic NK cell therapies designed to address B-cell driven autoimmune diseases through enhanced antibody-dependent cellular cytotoxicity. ask →
• CABALETTA BIO INC (CABA) Health Care — Cabaletta Bio is a clinical-stage biotechnology company developing CARTA engineered T cell therapies intended to provide durable, potentially curative, one-time treatments for patients with a wide range of autoimmune diseases. ask →
• ABEONA THERAPEUTICS INC (ABEO) Health Care — Abeona Therapeutics is a commercial-stage biopharmaceutical firm providing the first autologous cell-based gene therapy for the treatment of rare, debilitating RDEB skin wounds. ask →
• CENTURY THERAPEUTICS INC (IPSC) Health Care — Century Therapeutics is pioneering scalable, off-the-shelf allogeneic cell therapies using an iPSC-derived platform to treat autoimmune diseases and cancer. ask →
• LINEAGE CELL THERAPEUTICS INC (LCTX) Health Care — Lineage Cell Therapeutics is a clinical-stage biotech developing off-the-shelf, allogeneic cell therapies for degenerative diseases of the eye, spinal cord, and auditory system. ask →
• CARTESIAN THERAPEUTICS INC (RNAC) Health Care — Cartesian Therapeutics is pioneering mRNA-engineered cell therapies designed to provide durable autoimmune disease treatment without the toxicity associated with conventional DNA-based CAR-T therapies. ask →
• ORGANOGENESIS HOLDINGS INC CLASS A (ORGO) Health Care — A regenerative medicine company providing advanced wound care and surgical tissue-engineered products to improve healing outcomes in patients with chronic and acute wounds. ask →
• NKARTA INC (NKTX) Health Care — Nkarta is a clinical-stage biotechnology company pioneering off-the-shelf, engineered natural killer (NK) cell therapies to treat autoimmune diseases by depleting pathogenic B cells. ask →
• PROTARA THERAPEUTICS INC (TARA) Health Care — Clinical-stage biopharmaceutical company developing TARA-002 for bladder cancer and rare lymphatic malformations, and IV Choline Chloride for patients on parenteral support. ask →
• MaxCyte, Inc. (MXCT) Health Care — MaxCyte provides high-performance, non-viral cell engineering platforms and gene-editing assessment services that enable the development of next-generation cell and gene therapies. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-10-08.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.